272 related articles for article (PubMed ID: 28315910)
1. Effect of selenium supplementation for protection of salivary glands from iodine-131 radiation damage in patients with differentiated thyroid cancer.
Son H; Lee SM; Yoon RG; Lee H; Lee I; Kim S; Chung WY; Lee JW
Hell J Nucl Med; 2017; 20(1):62-70. PubMed ID: 28315910
[TBL] [Abstract][Full Text] [Related]
2. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
Nakada K; Ishibashi T; Takei T; Hirata K; Shinohara K; Katoh S; Zhao S; Tamaki N; Noguchi Y; Noguchi S
J Nucl Med; 2005 Feb; 46(2):261-6. PubMed ID: 15695785
[TBL] [Abstract][Full Text] [Related]
3. Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer?
Fallahi B; Beiki D; Abedi SM; Saghari M; Fard-Esfahani A; Akhzari F; Mokarami B; Eftekhari M
Nucl Med Commun; 2013 Aug; 34(8):777-86. PubMed ID: 23708871
[TBL] [Abstract][Full Text] [Related]
4. Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer: a randomized-controlled trial.
Upadhyaya A; Zhou P; Meng Z; Wang P; Zhang G; Jia Q; Tan J; Li X; Hu T; Liu N; Wang S; Liu X; Wang H; Zhang C; Zhao F; Yan Z; Wang X; Zhang X; Zhang W
Nucl Med Commun; 2017 Nov; 38(11):891-903. PubMed ID: 28806348
[TBL] [Abstract][Full Text] [Related]
5. Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms.
Jeong SY; Kim HW; Lee SW; Ahn BC; Lee J
Thyroid; 2013 May; 23(5):609-16. PubMed ID: 23153322
[TBL] [Abstract][Full Text] [Related]
6. Effects of first radioiodine ablation on functions of salivary glands in patients with differentiated thyroid cancer.
Upadhyaya A; Meng Z; Wang P; Zhang G; Jia Q; Tan J; Li X; Hu T; Liu N; Zhou P; Wang S; Liu X; Wang H; Zhang C; Zhao F; Yan Z
Medicine (Baltimore); 2017 Jun; 96(25):e7164. PubMed ID: 28640094
[TBL] [Abstract][Full Text] [Related]
7. [Salivary gland damage after 131I therapy in patients with differentiated thyroid cancer. Preliminary report].
Macioszek A; Baczyk M; Kopeć T; Sowiński J
Endokrynol Pol; 2008; 59(5):403-10. PubMed ID: 18979451
[TBL] [Abstract][Full Text] [Related]
8. Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy.
Raza H; Khan AU; Hameed A; Khan A
Nucl Med Commun; 2006 Jun; 27(6):495-9. PubMed ID: 16710103
[TBL] [Abstract][Full Text] [Related]
9. Prediction of risk for symptomatic sialadenitis by post-therapeutic dual (131)I scintigraphy in patients with differentiated thyroid cancer.
Lee SM; Lee JW; Kim SY; Han SW; Bae WK
Ann Nucl Med; 2013 Oct; 27(8):700-9. PubMed ID: 23921836
[TBL] [Abstract][Full Text] [Related]
10. Assessment of salivary gland dysfunction after radioiodine therapy for thyroid carcinoma using non-contrast-enhanced CT: the significance of changes in volume and attenuation of the glands.
Nabaa B; Takahashi K; Sasaki T; Okizaki A; Aburano T
AJNR Am J Neuroradiol; 2012 Nov; 33(10):1964-70. PubMed ID: 22555571
[TBL] [Abstract][Full Text] [Related]
11. Effects of postoperative antioxidants on the salivary glands in patients with thyroid cancer undergoing radioactive iodine-131 treatment.
Tong H; Yue R; Fang J; Li X; Yang S; Hou Y; Wang R; Zhang B; Liu H; Wu Z; Cheng Y
Nucl Med Commun; 2024 Apr; 45(4):312-320. PubMed ID: 38312062
[TBL] [Abstract][Full Text] [Related]
12. Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study.
Klein Hesselink EN; Brouwers AH; de Jong JR; van der Horst-Schrivers AN; Coppes RP; Lefrandt JD; Jager PL; Vissink A; Links TP
J Nucl Med; 2016 Nov; 57(11):1685-1691. PubMed ID: 27339871
[TBL] [Abstract][Full Text] [Related]
13. Differentiated thyroid cancer and selenium supplements for protection of salivary glands from
Mazokopakis E
Hell J Nucl Med; 2018; 21(1):83-84. PubMed ID: 29550852
[TBL] [Abstract][Full Text] [Related]
14. Iodine kinetics and dosimetry in the salivary glands during repeated courses of radioiodine therapy for thyroid cancer.
Liu B; Huang R; Kuang A; Zhao Z; Zeng Y; Wang J; Tian R
Med Phys; 2011 Oct; 38(10):5412-9. PubMed ID: 21992360
[TBL] [Abstract][Full Text] [Related]
15. Salivary gland protection with sialagogues: a case study.
Van Nostrand D; Atkins F; Bandaru VV; Chennupati SP; Moreau S; Burman K; Wartofsky L
Thyroid; 2009 Sep; 19(9):1005-8. PubMed ID: 19500022
[TBL] [Abstract][Full Text] [Related]
16. Effects of Salivary Secretion Stimulation on the Treatment of Chronic Radioactive Iodine-Induced Sialadenitis.
Choi JS; Hong SB; Hyun IY; Lim JY; Kim YM
Thyroid; 2015 Jul; 25(7):839-45. PubMed ID: 25809840
[TBL] [Abstract][Full Text] [Related]
17. Salivary gland function in thyroid cancer patients with radioiodine administration history.
Krcalova E; Horacek J; Gabalec F; Zak P; Dolezal J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Sep; 164(3):277-283. PubMed ID: 31223135
[TBL] [Abstract][Full Text] [Related]
18. Salivary gland protection by amifostine in high-dose radioiodine treatment: results of a double-blind placebo-controlled study.
Bohuslavizki KH; Klutmann S; Brenner W; Mester J; Henze E; Clausen M
J Clin Oncol; 1998 Nov; 16(11):3542-9. PubMed ID: 9817273
[TBL] [Abstract][Full Text] [Related]
19. Systematic evaluation of salivary gland damage following I-131 therapy in differentiated thyroid cancer patients by quantitative scintigraphy and clinical follow-up.
Wu JQ; Feng HJ; Ouyang W; Sun YG; Chen P; Wang J; Xian JL; Huang LH
Nucl Med Commun; 2015 Aug; 36(8):819-26. PubMed ID: 25932534
[TBL] [Abstract][Full Text] [Related]
20. Sialadenitis after radioiodine therapy. Analysis of factors that influence the response to medical treatment.
Geres AE; Mereshian PS; Fernández S; Rey Caro DG; Castro R; Podio R; Ojeda S
Endocrinol Nutr; 2015 Dec; 62(10):493-8. PubMed ID: 26459118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
